GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » EBITDA Margin %

MedMen Enterprises (MedMen Enterprises) EBITDA Margin % : -79.72% (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. MedMen Enterprises's EBITDA for the three months ended in Mar. 2023 was $-21.7 Mil. MedMen Enterprises's Revenue for the three months ended in Mar. 2023 was $27.2 Mil. Therefore, MedMen Enterprises's EBITDA margin for the quarter that ended in Mar. 2023 was -79.72%.


MedMen Enterprises EBITDA Margin % Historical Data

The historical data trend for MedMen Enterprises's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises EBITDA Margin % Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -222.66 -182.34 -269.22 -31.21 -75.80

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.63 -287.23 -8.18 2.39 -79.72

Competitive Comparison of MedMen Enterprises's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's EBITDA Margin % falls into.



MedMen Enterprises EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

MedMen Enterprises's EBITDA Margin % for the fiscal year that ended in Jun. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2022 )/Revenue (A: Jun. 2022 )
=-106.731/140.812
=-75.80 %

MedMen Enterprises's EBITDA Margin % for the quarter that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-21.705/27.225
=-79.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMen Enterprises  (OTCPK:MMNFQ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


MedMen Enterprises EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

MedMen Enterprises (MedMen Enterprises) Headlines

From GuruFocus

Q1 2021 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

MedMen Announces Management and Board Changes

By Business Wire 01-24-2024

MedMen Enterprises Announces Change of Auditor

By Business Wire Business Wire 03-23-2023

MedMen Provides Annual Filing Status Report

By Business Wire 11-17-2023

Q4 2021 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

MedMen Announces Resignation of Chief Financial Officer

By Business Wire Business Wire 06-16-2023

MedMen Provides Annual Filing Status Report

By Business Wire 11-30-2023

Q1 2022 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024